MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000547717

Медицинская библиотека · International archives of allergy and immunology · 2025

Comparative Efficacy of Oral and Intravenous Cyclophosphamide in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease and Analysis of Its Influencing Factors: A Clinical Trial.

Liu Wei, Huang Yumin, Yang Xichao, Liu Jie, Cao Xue, Feng Yuan

СтатьяСравнительное исследованиеКлиническое исследованиеПеревод в очереди

Аннотация

INTRODUCTION

Connective tissue disease (CTD) commonly affects the lungs, with interstitial lung disease (ILD) as its main complication; although cyclophosphamide (CTX) is the standard immunosuppressant for CTD-ILD, the optimal route of administration (oral vs. intravenous) remains unclear. This research aimed to analyze the efficacy of oral and intravenous CTX in the treatment of CTD-ILD and analysis of its influencing factors.

METHODS

The CTX per oral group (PO group) and intravenous infusion of CTX group (IV group) were established. Clinical efficacy, pulmonary function indices, pulmonary high-resolution computed tomography (HRCT) scores, blood gas parameters, 6-min walking distance (6MWD), SGRQ scores, serum levels of Krebs von den Lungen-6 (KL-6), 25-hydroxyvitamin D (25(OH)D), interferon-gamma (IFN-γ), and interleukin-4 (IL-4), and adverse reactions were examined. Relevant factors influencing the clinical efficacy of CTD-ILD were analyzed.

RESULTS

After treatment, patients in the IV group exhibited lower HRCT score, SGRQ scores, and serum levels of KL-6 and IL-4 compared to those in the PO group. Conversely, the IV group had higher levels of forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), diffusion capacity of the lung for carbon monoxide, FEV1/FVC ratio, partial pressure of oxygen, 6MWD, 25(OH)D, and IFN-γ. Higher serum levels of KL-6 and lower levels of 25(OH)D were associated with poorer treatment outcomes.

CONCLUSION

For patients with CTD-ILD, intravenous infusion of CTX for 12 months demonstrates superior efficacy compared to oral administration, with a lower incidence of adverse reactions.

Для цитирования: Liu Wei, Huang Yumin, Yang Xichao, Liu Jie, Cao Xue, Feng Yuan. Comparative Efficacy of Oral and Intravenous Cyclophosphamide in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease and Analysis of Its Influencing Factors: A Clinical Trial.. International archives of allergy and immunology. 2025. DOI: 10.1159/000547717.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.